Patents by Inventor Matthias Heinrichs

Matthias Heinrichs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multi-Layer Film, Injection Molded Article Decorated Therewith and Process for the Production of the Decorated Injection Molded Article
    Publication number: 20080213541
    Abstract: The invention concerns multi-layer films for back-molding with a liquid plastic material in an inmold process for the production of a decorated injection molded article of high optical quality and utilitarian suitability, in particular having curved surfaces, wherein the multi-layer film has at least one replication lacquer layer which at least on one of its surfaces has a spatial structure producing a visually perceptible and/or technical effect, wherein a contrast layer which is preferably in the form of a reflection layer is arranged in adjoining relationship with at least one surface with a spatial structure at least in region-wise manner. The invention further concerns an injection molded article which is decorated with a multi-layer film and a process for the production of the article.
    Type: Application
    Filed: February 3, 2006
    Publication date: September 4, 2008
    Inventors: Andreas Schilling, Matthias Heinrich, Andreas Hirschfelder
  • Indole or benzimidazole derivatives as CB1 inverse agonists
    Patent number: 7384945
    Abstract: Provided are compounds of the formula I: and pharmaceutically acceptable salts thereof, processes for making said compounds and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said compound and pharmaceutically acceptable salts thereof, and methods of using said compounds. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: June 10, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Konrad Bleicher, Matthias Heinrich Nettekoven, Philippe Pflieger, Stephan Roever
  • Inventory management
    Patent number: 7383284
    Abstract: Methods and apparatus, including computer program products, implementing and using techniques for inventory management. Managing data items in an inventory management system. A request to add a data item to the inventory management system is received. The data item has an associated set of attributes to be represented in the inventory management system. It is determined whether the inventory management system includes a structure in which the data item and the sets of attributes associated with the data item can be represented. If no structure exists in which the data item and the set of attributes associated with the data item can be represented, a new structure is automatically defined in which the data item and the set of attributes associated with the data item can be represented. The data item and the set of attributes associated with the data item is added to the defined new structure.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: June 3, 2008
    Assignee: SAP Aktiengesellschaft
    Inventors: Matthias Heinrichs, Pascale Van Laethem, Markus Seng, Achim Heger
  • BENZOYL-PIPERAZINE DERIVATIVES
    Publication number: 20080119486
    Abstract: The invention relates to compounds of formula wherein the substituents are described herein. The compounds may be used in the treatment of illnesses based on the glycine uptake inhibitor, such as psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 22, 2008
    Inventors: Synese Jolidon, Robert Narquizian, Matthias Heinrich Nettekoven, Roger David Norcross, Emmanuel Pinard, Henri Stalder
  • Consistent set of interfaces derived from a business object model
    Publication number: 20080120129
    Abstract: A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction.
    Type: Application
    Filed: May 11, 2007
    Publication date: May 22, 2008
    Inventors: Michael Seubert, Achim Heger, Adam Polly, Alexander Adam, Alexander Zaichenko, Alexandra Mark, Andre Doerfler, Andre Wachholz-Prill, Andre Wagner, Andrea Pluemper, Andreas Bold, Andreas Brossler, Andreas Huppert, Andreas Leukert-Knapp, Andreas Morsch, Andreas Neumann, Andreas Poth, Andreas Reccius, Andreas Wolber, Antje Fuchs, Antonia Gross, Arno Eifel, Artur Butucel, Arunava Banerjee, Ashwin Yeddula, Axel Kuehl, Benjamin Klehr, Bernd Schmitt, Bjoern Eike, Boris Krems, Christian Auth, Christian Fuhlbruegge, Christiane Cramer, Christiane Schauerte, Christopher Engler, Cristina Buchholz, Damian Theil, Daniel Bock, Daniel Zimmermann, Danny Pannicke, Dieter Krisch, Dietmar Nowotny, Dirk Henrich, Dirk Richtsteiger, Dirk Schindewolf, Doris Karbach, Frank Damaschke, Frank Hastrich, Frank Krueger, Frank Lindqvist, Frank Milpetz, Frank Reinemuth, Galina Pacher, Georg Dopf, Georg Podhajsky, Giovanni Deledda, Guimei Zhang, Gunther Liebich, Heike Berger, Hendrik Geipel, Horst Schaude, Ingo Bruss, Ingo Pfitzner, Jaakob Kind, Jan Hrastnik, Jan Richert, Joachim Liebler, Joachim Puteick, Jochen Steinbach, Joerg Goetting, Johannes Bechtold, Julian Schmidt-Kluegmann, Kai-Michael Roesner, Karsten Kimme, Karsten Koetter, Kathrin Nos, Klaus Herter, Klaus Reinelt, Klaus Schlappner, Kristina Grunewald, Levente Sara, Markus Juchem, Martin Gaub, Martin Hermes, Martin Rogge, Martin Schorr, Mathias Schoenecker, Matthias Asal, Matthias Heinrichs, Matthias Schmitt, Michael Bauer, Michael Conrad, Michael Hartel, Michael Jung, Michael Schier, Michael Segler, Michael Sylvester, Naci Kalyoncu, Olaf Meincke, Oliver Grande
  • Thiazole derivatives
    Patent number: 7371751
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors, including obesity.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: May 13, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Matthias Heinrich Nettekoven, Stephan Roever
  • Indole derivatives as H3 inverse agonists
    Patent number: 7361682
    Abstract: The present invention relates to compounds of formula I: wherein X, R1, R2, R3, R4 and R5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: April 22, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Silvia Gatti McArthur, Cornelia Hertel, Matthias Heinrich Nettekoven, Susanne Raab, Olivier Roche, Rosa Maria Rodriguez-Sarmiento, Franz Schuler, Jean-Marc Plancher
  • Benzoyl-piperazine derivatives
    Patent number: 7319099
    Abstract: The invention relates to compounds of formula wherein the substituents are described herein. The compounds may be used in the treatment of illnesses based on the glycine uptake inhibitor, such as psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: January 15, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Synese Jolidon, Robert Narquizian, Matthias Heinrich Nettekoven, Roger David Norcross, Emmanuel Pinard, Henri Stadler
  • Pyrazinecarboxamide derivatives as CB1 antagonists
    Publication number: 20070293509
    Abstract: The present invention relates to compounds of the formula I: wherein R1 to R8 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors, such as obesity.
    Type: Application
    Filed: May 30, 2007
    Publication date: December 20, 2007
    Inventors: Paul Hebeisen, Hans Iding, Matthias Heinrich Nettekoven, Ulrike Obst Sander, Stephan Roever, Urs Weiss, Beat Wirz
  • Piperidinyl pyrimidine derivatives
    Publication number: 20070281921
    Abstract: The present invention relates to compounds of formula I and their pharmaceutically acceptable salts wherein formula I is: wherein X, Y, Z, R1 and R2 are as defined in the description and claims. The compounds of the present invention act as antagonists and/or inverse agonists at the histamine 3 receptor and are useful for the treatment and/or prevention of diseases such as obesity, metabolic syndrome (syndrome X), and other eating disorders.
    Type: Application
    Filed: May 21, 2007
    Publication date: December 6, 2007
    Inventors: Matthias Heinrich Nettekoven, Olivier Roche
  • IH-indol-5-YL-piperazin-1-YL-methanone derivatives
    Publication number: 20070270423
    Abstract: The present invention relates to compounds of formula I and their pharmaceutically acceptable salts wherein in formula I is: wherein R1 to R4 are as defined in the description and claims. The compounds of the present invention are useful for the treatment and/or prevention of diseases which are associated with the modulation of histamine 3 (H3) receptors.
    Type: Application
    Filed: April 26, 2007
    Publication date: November 22, 2007
    Inventors: Matthias Heinrich Nettekoven, Olivier Roche
  • Benzothiazolyl derivatives
    Patent number: 7297707
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3 R3a and R3b are as provided in the description, and pharmaceutically acceptable salts thereof, for use in the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors such as obesity.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: November 20, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Matthias Heinrich Nettekoven, Stephan Roever
  • MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS
    Publication number: 20070237848
    Abstract: Methods and compositions for inhibiting 5-Lipoxygenase, 15-Lipoxygenase, COX-1, COX-2, Interleukin-l?, Interleukin-6, ?, HLE, and iNOS. Methods and compositions for treating and preventing diseases, including inflammatory diseases and skin cancer. Compositions comprising processed Morinda citrifolia components, some of which include leaf extracts, leaf juice, and/or seed extracts.
    Type: Application
    Filed: December 20, 2006
    Publication date: October 11, 2007
    Inventors: Brad Rawson, Matthias-Heinrich Krenter, Kim Asay, Afa Paln, Bing-Nan Zhou, Brett West, Claude Jensen
  • Thiazole derivatives
    Patent number: 7265109
    Abstract: Compounds of formula I as well as pharmaceutically acceptable salts and esters thereof, wherein the substituents have the significance given in the specification, and the compounds are neuropeptide Y(NPY) antagonists which are useful in the treatment of obesity.
    Type: Grant
    Filed: August 10, 2004
    Date of Patent: September 4, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Werner Neidhart, Matthias Heinrich Nettekoven, Philippe Pflieger, Sven Taylor
  • Neuropeptide Y antagonists
    Patent number: 7265125
    Abstract: Quinoline and quinazoline derivatives can be used in the form of pharmaceutical preparations as Neuropeptide Y antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: September 4, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Volker Breu, Frank Dautzenberg, Philippe Guerry, Matthias Heinrich Nettekoven, Philippe Pflieger
  • Naphthaline derivatives as H3 inverse agonists
    Patent number: 7259158
    Abstract: The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: August 21, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Silvia Gatti McArthur, Cornelia Hertel, Matthias Heinrich Nettekoven, Jean-Marc Plancher, Susanne Raab, Olivier Roche, Rosa Maria Rodriguez-Sarmiento, Franz Schuler
  • Aminothiazole derivatives
    Patent number: 7253197
    Abstract: Compounds of formula I as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in the specification, and the compounds, salts and esters can be used for the treatment of obesity.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: August 7, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Wolfgang Guba, Patrizio Mattei, Werner Neidhart, Matthias Heinrich Nettekoven, Philippe Pflieger
  • Thiazole derivatives
    Patent number: 7250431
    Abstract: Thiazole derivatives of formula I are provided as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5, a and b have the significance given in the specification. The compounds are neuropeptide Y Y5 receptor antagonists which can be used for the treatment of obesity.
    Type: Grant
    Filed: August 10, 2004
    Date of Patent: July 31, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Werner Neidhart, Matthias Heinrich Nettekoven, Philippe Pflieger
  • Reconciliation method and apparatus
    Publication number: 20070156546
    Abstract: A method includes selecting a set of transaction records from an accounting function, selecting a set of transaction records from a logical deployment unit, and checking the set of transaction records from the accounting function against the set of transaction records from a logical deployment unit, wherein the accounting function is separate from the logical deployment unit. A system includes a logical deployment unit, an accounting component separate from the logical deployment unit, a messaging system for sending messages from the logical deployment unit to the accounting component, and a checking mechanism.
    Type: Application
    Filed: December 30, 2005
    Publication date: July 5, 2007
    Inventors: Till Oppert, Paola Sala, Georg Podhajsky, Joachim Welte, Markus Klein, Wolfgang Barheine, Matthias Heinrichs, Tanja Soehngen, Pascal Hochwarth, Michael Sylvester
  • Pyridine-3-carboxamide derivatives as CB1 inverse agonists
    Patent number: 7229999
    Abstract: The present invention relates to compounds of the formula wherein X and R1 to R8 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors, such as obesity.
    Type: Grant
    Filed: April 4, 2006
    Date of Patent: June 12, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Paul Hebeisen, Hans Iding, Matthias Heinrich Nettekoven, Ulrike Obst, Stephan Roever, Beat Wirz